Couverture de PMHNP Certification Q & A

PMHNP Certification Q & A

PMHNP Certification Q & A

De : Fitzgerald Health Education Associates
Écouter gratuitement

Offres de saison | 0,99 € par mois pendant les 3 premiers mois

5,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.

This podcast is for NP students studying to pass their PMHNP certification exam. Expert Fitzgerald faculty clinicians share their knowledge and experience to help you dissect the anatomy of a test question so you can better understand how to arrive at the correct test answer.

© 2026 PMHNP Certification Q & A
Épisodes
  • Substance Treatment Analysis
    Oct 28 2026

    The PMHNP is performing a follow-up visit on a 41-year-old female who is being treated for obsessive-compulsive disorder. She has been seeing an exposure-response therapist for over six months, and approximately two months ago both patient and the therapist felt that pharmacotherapy should be considered. The patient was started on fluoxetine and was rapidly titrated up to 40 mg day two months ago. Today in follow-up the patient’s Y-BOCS score is 23, as compared to a 24 when she started her medication 2 months ago. Subjectively she feels distinct improvement. She still loses time to both her obsessive thoughts and occasionally her husband has to pick her up and carry her from bed to living room because of her obsession about touching the floor. But, she feels encouraged and genuinely feels as though things are better.

    The appropriate course of action today would be to do which of the following?

    A. Increase her fluoxetine to 60 mg day

    B. Change her SSRI to fluvoxamine rapidly tapering to 300 mg/day

    C. Continue the current plan of care and follow-up in one month

    D. Discuss with her a change of therapeutic modality to EMDR.

    ---

    YouTube: https://www.youtube.com/watch?v=UIuwwA5N63I&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=144



    Afficher plus Afficher moins
    8 min
  • PHQ-9 Depression Assessment
    Oct 21 2026

    The PMHNP is reviewing the results of a comprehensive new patient assessment and notes that the result of the patient health questionnaire (PHQ)-9 is a 7. Knowing that the sensitivity of this screening tool is 90% for a score of 8 or more, the PMHNP recognizes that the likelihood that the patient is having a major depressive episode is:

    A. 10%

    B. 15%

    C. 85%

    D. 90%

    ---

    YouTube: https://www.youtube.com/watch?v=iK87yMniCNY&list=PLf0PFEPBXfq5HGfNV-GbOlYHtDwd35OeG&index=143

    Afficher plus Afficher moins
    9 min
  • Alcohol Behavior Assessment
    Oct 14 2026

    J.T. is a 38-year-old male patient who presents for assessment and treatment of substance use disorder. He has a long history of chronic alcohol use, typically drinking a 6-pack of beer every evening. According to his primary care provider his physical examination and laboratory studies are all within normal limits and there are no documented medical conditions.

    He admits that he personally does not truly believe he has substance use problem, but his wife does like the fact that he drinks, and they argue about it often. He loves his wife and does not want to argue, but he enjoys his beer and feels strongly that it is not hurting anything when he drinks. He thinks she is being unreasonable.

    The PMHNP recognizes that he is at what point in the change process?

    A. Precontemplative

    B. Focusing

    C. Unfreezing

    D. Planning


    Afficher plus Afficher moins
    9 min
adbl_web_anon_alc_button_suppression_t1
Aucun commentaire pour le moment